Ingrid Meinl
About
In The Last Decade
Ingrid Meinl
19 papers receiving 573 citations
Peers
Comparison fields: 5 of 50
- Pathology and Forensic Medicine 405
- Immunology 297
- Oncology 211
- Public Health, Environmental and Occupational Health 161
- Neurology 96
Countries citing papers authored by Ingrid Meinl
This map shows the geographic impact of Ingrid Meinl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid Meinl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid Meinl more than expected).
Fields of papers citing papers by Ingrid Meinl
This network shows the impact of papers produced by Ingrid Meinl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid Meinl. The network helps show where Ingrid Meinl may publish in the future.
Co-authorship network of co-authors of Ingrid Meinl
This figure shows the co-authorship network connecting the top 25 collaborators of Ingrid Meinl. A scholar is included among the top collaborators of Ingrid Meinl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingrid Meinl. Ingrid Meinl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 26 | |
| 3 | 11 | |
| 4 | 12 | |
| 5 | 45 | |
| 6 | 19 | |
| 7 | 5 | |
| 8 | 2 | |
| 9 | Long-term exposure to natalizumab during pregnancy - a prospective case series from the German Multiple Sclerosis and Pregnancy Registry | 4 |
| 10 | 2 | |
| 11 | 33 | |
| 12 | Disease course during pregnancy in patients with highly active multiple sclerosis | 1 |
| 13 | 138 | |
| 14 | 21 | |
| 15 | 133 | |
| 16 | 1 | |
| 17 | 47 | |
| 18 | 62 | |
| 19 | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.